The TB-500 study found activity in a metabolite rather than the parent in its wound assay. The cited papers do not test this exact pair.
Why these materials?
A literature comparison of cell-migration findings and TB-500 metabolism. Both touch tissue-model endpoints, so shared labels alone do not establish complementary effects.
BPC-157: tendon-fibroblast migration and FAK–paxillin findings in laboratory models.
TB-500: acetylated fragment and metabolite research; not interchangeable with full-length thymosin beta-4.
BPC-157 is a synthetic pentadecapeptide composed of 15 amino-acid residues. It belongs to the short synthetic peptide research category described in the catalog literature and is supplied as a sealed vial of lyophilized powder for laboratory research and analytical characterization.
TB-500 is a synthetic research peptide related to the actin-binding region of thymosin beta-4, rather than the full-length thymosin beta-4 sequence. It belongs to the thymosin-fragment family and is supplied as a sealed vial of lyophilized powder for laboratory research.
Lot documentation published
Stack price$85
One vial of each included product.
Individual value: $90Save $5
Ask about Recovery
Explore the details with our team.
Contact us for current availability and lot documentation for the products in this selection.
Laboratory research only. Goal labels describe research themes, not promised outcomes or combined-use guidance. Each product is a separate catalog record. Not for human or veterinary use.